pillbase.ru

Uptravi

Active substance: selexipag

selexipag

Centralised EU authorisationActive

Marketing holder: Janssen Cilag International NV

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 40
  • Selexipag
    TABLET, FILM COATED · SELEXIPAG 1200 ug/1
    70710-1556
    Zydus Pharmaceuticals (USA) Inc.
  • Selexipag
    TABLET, FILM COATED · SELEXIPAG 200 ug/1
    70771-1793
    Zydus Lifesciences Limited
  • Selexipag
    TABLET, FILM COATED · SELEXIPAG 1400 ug/1
    70771-1799
    Zydus Lifesciences Limited
  • Selexipag
    CAPSULE · SELEXIPAG .2 mg/1
    46014-0602
    Excella GmbH & Co. KG
  • Selexipag
    CAPSULE · SELEXIPAG .2 mg/1
    46014-0621
    Excella GmbH & Co. KG
All products in this country (40)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-45ff-7ce2-9cfe-d2b9c82b1a70,01a1208c-bb5c-76d0-9383-a070e346f46e,01a1208c-bcca-71e0-b66b-49e1d020e12d,01a1208c-bccc-7d61-8a65-dd8c3dab8d73,01a1208c-f5d6-7e87-9bfa-089937645f8f;count=40 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003774
Registration status
Active
ATC code
B01AC27
Sources
  • product · EMA · EMEA/H/C/003774 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003774 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003774 · Verified 2026-10-09